COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 27, 2021)
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
What just happenedOct 28, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 27, 2021
- Oct 28, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 27, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 27, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 27, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 27, 2021IntroReferralIntro-H
Introduced in House
- Oct 27, 2021IntroReferral1000
Introduced in House